﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2023v5.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-11-01T04:33:52-05:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>112973168</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>Dougherty &amp; Connell</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>450 Wireless Boulevard</AddressLine1Txt>
        <CityNm>Hauppauge</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>11788</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>454600661</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>MILSTEIN MEDICAL ASIAN-AMERICAN</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>PARTNERSHIP FOUNDATION INC</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>MILS</BusinessNameControlTxt>
      <PhoneNum>2128504505</PhoneNum>
      <USAddress>
        <AddressLine1Txt>6 East 43rd Street</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>ERIC KAPLAN</PersonNm>
      <PersonTitleTxt>SECRETARY</PersonTitleTxt>
      <PhoneNum>2128504505</PhoneNum>
      <SignatureDt>2024-11-01</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>1</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>Kevin P Dougherty</PreparerPersonNm>
      <PTIN>P00189079</PTIN>
      <PhoneNum>6317562100</PhoneNum>
      <PreparationDt>2024-11-01</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>HOWARD P MILSTEIN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>6 EAST 43RD STREET- 3RD FLOOR</AddressLine1Txt>
        <CityNm>NY</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>871409</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>N/A</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2012</FormationYr>
      <LegalDomicileStateCd>DE</LegalDomicileStateCd>
      <ActivityOrMissionDesc>The mission of the Milstein Medical Asian American Partnership Foundation (MMAAP Foundation) is to improve world health by developing mutually beneficial partnerships between the United States and China, as well as greater Asia. Working with some of the premier health organizations in the world, the MMAAP Foundation will bring together and fund exchanges among the best research, medical talent, and institutions in the regions. This strategy is a high priority for its founders, Howard P. Milstein and the Paul and Irma Milstein Foundation.The MMAAP Foundation is designed to become a highly respected international foundation demonstrating expertise in producing medical and scientific progress with integrity and efficiency.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>5</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>4</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>5</TotalEmployeeCnt>
      <TotalVolunteersCnt>0</TotalVolunteersCnt>
      <TotalGrossUBIAmt>93</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>771747</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>871316</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>564</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>93</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>0</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>772311</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>871409</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>135000</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>160000</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>636754</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>656214</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>48593</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>74176</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>820347</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>890390</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-48036</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-18981</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>54234</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>50037</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>77002</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>83059</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>-22768</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>-33022</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>The mission of the Milstein Medical Asian American Partnership Foundation (MMAAP Foundation) is to improve world health by developing mutually beneficial partnerships between the United States and China, as well as greater Asia. Working with some of the premier health organizations in the world, the MMAAP Foundation will bring together and fund exchanges among the best research, medical talent, and institutions in the regions. This strategy is a high priority for its founders, Howard P. Milstein and the Paul and Irma Milstein Foundation.The MMAAP Foundation is designed to become a highly respected international foundation demonstrating expertise in producing medical and scientific progress with integrity and efficiency.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>582103</ExpenseAmt>
      <GrantAmt>60000</GrantAmt>
      <Desc>2023 Irma and Paul Milstein Program for Senior Health Awards: Research Project Award:Project Title: Prognostic Analysis and Tumor Immune Microenvironment Feature of lntraductal Papillary Mucinous Neoplasm Associated Invasive Carcinoma in Older Adults Chinese Institution: Peking Union Medical College HospitalU.S. Institution: Johns Hopkins University</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>100000</ExpenseAmt>
        <GrantAmt>100000</GrantAmt>
        <Desc>2023 Irma and Paul Milstein Program for Senior Health Awards: Project Title: Aging Immunity and Viral Infections in Older adults U.S. Institution:Johns Hopkins UniversityPart of a multi year study</Desc>
      </ProgSrvcAccomActy2Grp>
      <TotalProgramServiceExpensesAmt>682103</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>0</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">0</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">0</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>0</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>5</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>5</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>1</ForeignFinancialAccountInd>
      <ForeignCountryCd>CH</ForeignCountryCd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>5</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>4</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>1</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>1</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>1</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>KEVIN BUCKLEY CPA TREASURER</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>2127080870</PhoneNum>
        <USAddress>
          <AddressLine1Txt>335 MADISON AVE 14TH FLOOR</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>Howard P Milstein</PersonNm>
        <TitleTxt>Chair *</TitleTxt>
        <AverageHoursPerWeekRt>0.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Abby S Milstein</PersonNm>
        <TitleTxt>Director *</TitleTxt>
        <AverageHoursPerWeekRt>0.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Sean X Leng MD PhD</PersonNm>
        <TitleTxt>President *</TitleTxt>
        <AverageHoursPerWeekRt>8.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>245000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Gerald Lazarus MD</PersonNm>
        <TitleTxt>Founding President *</TitleTxt>
        <AverageHoursPerWeekRt>0.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Michael W Hodin PhD</PersonNm>
        <TitleTxt>Director *</TitleTxt>
        <AverageHoursPerWeekRt>0.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Eric Kaplan Esq</PersonNm>
        <TitleTxt>Board Secretary *</TitleTxt>
        <AverageHoursPerWeekRt>0.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Kevin Buckley</PersonNm>
        <TitleTxt>Treasurer *</TitleTxt>
        <AverageHoursPerWeekRt>0.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Kathleen Reichert</PersonNm>
        <TitleTxt>Senior Vice President</TitleTxt>
        <AverageHoursPerWeekRt>20.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>255000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Charles Wang</PersonNm>
        <TitleTxt>Advisory Committee *</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Pablo Rubinstein MD</PersonNm>
        <TitleTxt>Advisory Committee *</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>60000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Average hours worked per week for</PersonNm>
        <TitleTxt>all officers and directors</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Except as noted are</PersonNm>
        <TitleTxt>As Required</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>560000</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>0</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>871316</AllOtherContributionsAmt>
      <NoncashContributionsAmt>8316</NoncashContributionsAmt>
      <TotalContributionsAmt>871316</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>93</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>93</UnrelatedBusinessRevenueAmt>
      </InvestmentIncomeGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>871409</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>93</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>0</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>110000</TotalAmt>
        <ProgramServicesAmt>110000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>50000</TotalAmt>
        <ProgramServicesAmt>50000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>586750</TotalAmt>
        <ProgramServicesAmt>425550</ProgramServicesAmt>
        <ManagementAndGeneralAmt>161200</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>45260</TotalAmt>
        <ProgramServicesAmt>40734</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4526</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <PayrollTaxesGrp>
        <TotalAmt>24204</TotalAmt>
        <ProgramServicesAmt>21783</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2421</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>4653</TotalAmt>
        <ManagementAndGeneralAmt>4653</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>15363</TotalAmt>
        <ManagementAndGeneralAmt>15363</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>2467</TotalAmt>
        <ManagementAndGeneralAmt>2467</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>612</TotalAmt>
        <ManagementAndGeneralAmt>612</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>1745</TotalAmt>
        <ProgramServicesAmt>1047</ProgramServicesAmt>
        <ManagementAndGeneralAmt>698</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>39129</TotalAmt>
        <ProgramServicesAmt>32012</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7117</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>8728</TotalAmt>
        <ManagementAndGeneralAmt>8728</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalAmt>1286</TotalAmt>
        <ProgramServicesAmt>823</ProgramServicesAmt>
        <ManagementAndGeneralAmt>463</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>DELIVERY &amp; POSTAGE</Desc>
        <TotalAmt>193</TotalAmt>
        <ProgramServicesAmt>154</ProgramServicesAmt>
        <ManagementAndGeneralAmt>39</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>890390</TotalAmt>
        <ProgramServicesAmt>682103</ProgramServicesAmt>
        <ManagementAndGeneralAmt>208287</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>43885</BOYAmt>
        <EOYAmt>32056</EOYAmt>
      </CashNonInterestBearingGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>10349</BOYAmt>
        <EOYAmt>17981</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>54234</BOYAmt>
        <EOYAmt>50037</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>47002</BOYAmt>
        <EOYAmt>53059</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>30000</BOYAmt>
        <EOYAmt>30000</EOYAmt>
      </GrantsPayableGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>77002</BOYAmt>
        <EOYAmt>83059</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>-22768</BOYAmt>
        <EOYAmt>-33022</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>-22768</BOYAmt>
        <EOYAmt>-33022</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>54234</BOYAmt>
        <EOYAmt>50037</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>-18981</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>8727</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>1088000</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>873500</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>711668</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>765668</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>871316</CurrentTaxYearAmt>
        <TotalAmt>4310152</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>1088000</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>873500</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>711668</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>765668</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>871316</CurrentTaxYearAmt>
        <TotalAmt>4310152</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>3771460</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>538692</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>37</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>21</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>77</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>564</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>93</CurrentTaxYearAmt>
        <TotalAmt>792</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>4310944</TotalSupportAmt>
      <PublicSupportCY170Pct>0.12500</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.12740</PublicSupportPY170Pct>
      <TenPctFactsCrcmstncsTestCYInd>X</TenPctFactsCrcmstncsTestCYInd>
      <FactsAndCircumstancesTestTxt>Milstein Medical Asian American Partnership (MMAAP) Foundation satisfied the requirements of the "facts-and-circumstances" test for 2023 and maintained a continuous and bona fide program to solicit funds from the general public. Foundation leadership conducted regular activities/events to maintain and attract support from governmental or other publicly oriented organizations by proving that the: (1) MMAAP Foundation's scope of fundraising activities is growing and expanding. (2) MMAAP Foundation relies on limited sources or amount of support, while expanding our solicitation program and/or activities. (3) Facts and circumstances of the MMAAP Foundation's case can be analyzed in accordance with our nature and purpose. (4) MMAAP Foundation's public support is derived from a representative number of individuals, corporations, and foundations. (5) MMAAP Foundation's governing body represents the broad interests of the public rather than the private interests of a selected number of donors. (6) MMAAP Foundation provides funds for scientific discovery and research for the benefit of the general public on a continuing basis. (7) MMAAP Foundation's activities are appealing to persons having some broad common interest or purpose. In 2023, the MMAAP Foundation continued its operations and actively participated in national/international conferences to promote its mission while seeking community support. MMAAP maintained its fundraising activities and cultivated new donors by connecting with high-level entities and individuals. Additionally, MMAAP engaged with business leaders, physicians, and philanthropists, both virtually and in person, to exchange ideas and pursue potential opportunities.MMAAP is registered with Network for Good, Charity Navigator, and Candid. Donors can contribute to MMAAP these websites. In 2023, MMAAP received the Candid Transparency Recognition and ranked in the top 5% of registered philanthropic organizations, showcasing its financial accountability.In February 2023, MMAAP celebrated the Lunar New Year with a card to all donors and friends of the foundation to thank for their continued support, maintain relationships with them for future engagement. In 2023, MMAAP President Dr. Sean Leng delivered keynote presentations and participated in roundtable discussions at the following conferences. He networked with physicians, key opinion leaders, and philanthropists within the geriatric industry, representing MMAAP to expand its impact:" Global Meningococcal Initiative (GMI) 11th Regional Meeting Meningococcal disease in the Middle East and Asia (virtual)." Huashan Research CrossTalk Series, Huashan Hospital, Fudan University (in-person)" Peking Union Medical College (PUMC) Hospital geriatrics seminar (in-person)" 1 st PUMC Hospital senior healthcare workforce development conference (in-person)" PUMC Basic Science Research Institute seminar (in person)" Academic Forum by Overseas Distinguished Professors, Tianjin Medical University (in-person)" 2023 Chinese Medical Association Geriatrics Branch annual scientific conference (in-person)" 13th PUMC - Hopkins annual national geriatrics conference (in-person)" Research seminar at Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine (in person)" 2023 European Geriatric Medicine AnnualDr. Leng is highly sought after and asked to play a significant role in major international conferences including the Annual Scientific Meeting of the Chinese Medical Association Geriatrics Branch in Wuhan. He was also invited to organize an International Symposium on Aging and Immune Remodeling at this year's Chinese Congress on Gerontology and Health Industry (CCGI) to be held on Hainan Island as well.During his May trip, Dr. Leng visited Mr. Qian Liu who's working on a healthcare diplomacy initiative inspired by the ping-pong diplomacy of the 1970s. They had a productive conversation. Additionally, Dr. Leng met with officials from the China Medical Board and the Bill Gates Foundation. Both recognized MMAAP's reputation and expertise in senior health expressed interest in continuing communication for potential collaboration. Dr. Leng also discussed the US-China dialogue on healthcare held at Duke, which was attended by notable figures and emphasized healthcare diplomacy. He reported on the Hevolution Foundation meeting in London, which focused on strategic planning with a significant budget aimed at promoting healthy aging. Dr. Leng represented MMAAP and integrated funding outreach messages within these activities.In 2023, MMAAP's leadership actively participated in the American Skin Association (ASA) Board Meeting and Advisory Committees, where they presented the foundation's work. Furthermore, they sought advice from Dr. Emma Guttman and Dr. Mark Lebwohl on corporate grant opportunities, acting upon their guidance and introductions to explore new funding avenues. They also attended webinars/Zoom meetings hosted by the China Institute and Committee of 100 to establish relationship with industry experts. MMAAP prepared collateral materials and updated activities, strategic plans, achievements, future opportunities, and areas of support for Advisory Board Member MMAAP prepared collateral materials and updated strategic plans, achievements, future opportunities, and areas of support for Advisory Board Members Mr. Steve Orlins from the National Committee on US-China Relations, Dr. Mike Hodin from the Global Coalition on Aging, Dr. Gerald Lazarus, and Dr. Pablo Rubinstein to leverage their networks for soliciting support.Dr. Mike Hodin presented MMAAP with the opportunity to explore funding interests at three roundtable dialogues. Representatives from leading pharmaceutical companies, including Gilead, Pfizer, and Sanofi, were engaged, showing specific interest in oncology innovation and activities in Asia. MMAAP leadership has presented and engaged with additional pharmaceutical corporations include Leo pharma, BMS, J&amp;J, etc. Additionally, MMAAP delivered presentations to Ms. Victoria Hsu of the J.T. Tai Foundation and Mr. Michael J. Duffalo of the Ping Y. Tai Foundation to seek potential support. Following these meetings, MMAAP followed up with both foundations by sending outreach letters and pledge forms.Throughout 2023, MMAAP sustained its engagement with Mr. Lester Ross from WilmerHale, identifying potential opportunities which culminated in a partnership with WilmerHale.MMAAP Chairman, Mr. Howard Milstein and Mrs. Abby Milstein was honored at The Johns Hopkins Center on Aging and Immune Remodeling (JH CAIR) event. During this occasion, they met with the leadership of the Johns Hopkins University (JHU) School of Medicine to discuss the continuation and enhancement of their relationship. The discussions led to a consensus on strengthening MMAAP's academic collaborations with JHU and other prominent medical institutions globally. This initiative aims to provide a superior platform for advancing research capabilities and program development.In conclusion, MMAAP consistently engages hundreds of potential supporters through a variety of communications, including holiday cards, and annual appeal mailings. Additionally, previously developed materials such as videos, brochures, folders, banners, and other collateral and exhibit materials have been distributed to specifically targeted potential donors, key personnel, and pharmaceutical companies.In the fall of 2023, MMAAP initiated its annual appeal campaign, reaching out to both past and prospective donors to seek unrestricted support. As a result, total donations to MMAAP in 2023 amounted to $863,000. The leadership of the MMAAP Foundation has dedicated over 400 hours to developing a strategic plan focused on expanding the current donor base.Since its founding, the MMAAP Foundation has awarded nearly 60 Fellowship and Research Project Awards to support the work of exceptional Chinese scientists and investigators from prestigious Chinese institutions. This support has resulted in the publication of over 260 scientific papers in leading English and Chinese journals within their respective medical fields, all acknowledging the MMAAP Foundation's contributions.</FactsAndCircumstancesTestTxt>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <TotalBookValueLandBuildingsAmt>0</TotalBookValueLandBuildingsAmt>
      <TotalRevEtcAuditedFinclStmtAmt>871409</TotalRevEtcAuditedFinclStmtAmt>
      <RevenueNotReportedAmt>0</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>871409</RevenueSubtotalAmt>
      <RevenueNotReportedFinclStmtAmt>0</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>871409</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>881663</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>881663</ExpensesSubtotalAmt>
      <OtherExpensesNotIncludedAmt>8727</OtherExpensesNotIncludedAmt>
      <ExpensesNotRptFinclStmtAmt>8727</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>890390</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part XII, Line 4b - Other Adjustments:</FormAndLineReferenceDesc>
        <ExplanationTxt>AMORTIZATION OF START UP COSTS</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific - Australia, Brunei, Burma, Cambodia,</RegionTxt>
        <OfficesCnt>1</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services; 2023 Senior Health Award in Geriatric Medicine; Research Project Award</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Project Title:Prognostic Analysis and Tumor Immune Microenvironment Feature oflntraductal Papillary Mucinous Neoplasm Associated Invasive Carcinoma in Older AdultsForeign Institution: China Academy of Chinese Medical Sciences Xiyuan Hospital</SpecificServicesProvidedTxt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>1</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>1</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>0</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>0</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific - Australia, Brunei, Burma, Cambodia,</RegionTxt>
        <PurposeOfGrantTxt>Project Name:Prognostic Analysis and Tumor Immune Microenvironment Feature oflntraductal Papillary Mucinous Neoplasm Associated Invasive Carcinoma in Older Adults</PurposeOfGrantTxt>
        <CashGrantAmt>50000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>Book</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>Pre- Approval: The Board of directors will review the foreign charitable organization's exempt purpose to determine whether they are analogous to the foundation's own exempt purposes and are within the purposes described in Section 170(c)(2) of the Internal Revenue Code. The foreign charitable organization should provide an IRS determination letter recognizing it as an organization described in IRC Section 501(c)(3) that is not a private foundation, or, an affidavit of its equivalency to, or an opinion of counsel that it is equivalent to, a US public charity (IRC Section 501(c)(3)tax-exempt, Section 509(a)(1), 509(a)(2) or 509(a)(3) public charity). The Board of Directors will confirm that none of the foreign charitable organization, it's officers, directors, and trustees, and any organizations and individuals that control it are listed on the Treasury Department's Office of Foreign Assets Control (OFAC) list of Specifically Designated Nationals. Grant agreements: The Board of Directors shall satisfy its fiduciary duty to insure that funds under its control are used solely for charitable purposes by exercising and documenting sufficient discretion and control over the use of funds it grants to each foreign charitable organization. The Foundation requires written grant agreements with each foreign charitable organization. Each of the agreements includes the following requirements regarding monitoring the use of funds: Periodic reports from the foreign grantee with accountings or line item financial reports sufficiently detailed to enable the Foundation to account for the use of the funds. Requires the foreign grantee to maintain records of receipts and expenses and make its books and records available to the Foundation at reasonable times. Requires the foreign grantee to provide written narrative and financial reports until the grant funds have been expended. The reports should describe use of the funds,compliance with the terms of the grant agreement, and progress made in accomplishing the purposes of the grant. Requires the foreign grantee to repay any funds not used for the grant's purpose. Requires that the grant funds be used only for public charitable purposes and does not allow the use of the funds to influence the outcome of any specific public election or to undertake any activity for a non-charitable purpose.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Johns Hopkins University School of Medicine -</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3400 N Charles Street</AddressLine1Txt>
          <CityNm>Baltimore</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>21218</ZIPCd>
        </USAddress>
        <RecipientEIN>520595110</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>10000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>Book</ValuationMethodUsedDesc>
        <PurposeOfGrantTxt>Project Name:Prognostic Analysis and Tumor Immune Microenvironment Feature oflntraductal Papillary Mucinous Neoplasm Associated Invasive Carcinoma in Older Adults</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Johns Hopkins University School of Medicine -</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3400 N Charles Street</AddressLine1Txt>
          <CityNm>Baltimore</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>21218</ZIPCd>
        </USAddress>
        <RecipientEIN>520595110</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>100000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>Book</ValuationMethodUsedDesc>
        <PurposeOfGrantTxt>Project Name: Aging Immunity and Viral Infections in Older Adults</PurposeOfGrantTxt>
      </RecipientTable>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>The Board of directors wil review the charitable organization's exempt purpose to determine whether they are analogous to the foundation's own exempt purposes and are within the purposes described in Section 170(c)(2) of the Internal Revenue Code. The charitable organization should provide an IRS determination letter recognizing it as an organization described in IRC Section 501(c)(3) that is not a private foundation or an affidavit of its equivalency. The grantee must provide annual written narrative and financial reports at the end of each of the grantee's accounting periods until the grant funds have been fully expended. Reports should describe use of the funds, compliance with the terms of the grant agreement, progress made in accomplishing the purpose of the grant.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <SubstantiationRequiredInd>1</SubstantiationRequiredInd>
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Kathleen Reichert</PersonNm>
        <TitleTxt>Senior Vice President</TitleTxt>
        <BaseCompensationFilingOrgAmt>255000</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>255000</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Sean X Leng MD PhD</PersonNm>
        <TitleTxt>President *</TitleTxt>
        <BaseCompensationFilingOrgAmt>200000</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>45000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>245000</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 1a</FormAndLineReferenceDesc>
        <ExplanationTxt>The board has adopted a plan to utilize the following when establishing the compensation for the foundations's employees and various consultants: Compensation Committee Written Contract Formal approval of the board The foundation maintains a written policy for all travel &amp; entertainment reimbursements requiring the filing of periodic expense reports including documentation.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section A, line 2</FormAndLineReferenceDesc>
        <ExplanationTxt>The family and business relationships among the officers and directors is as follows: Two of the directors, Howard P Milstein and Abby S Milstein are married to each other. Eric Kaplan, an officer of the foundation, is an employee of Bristol Consultants, LLC, which provides consulting services to Howard P Milstein and Milstein Family affiliates. Kevin Buckley, an officer of the foundation, is an employee of Milstein Consultants, Ltd. which is wholly owned by the Milstein family. One of the directors, Michael W Hodin, is on the board of Emigrant Bank, which is wholly owned by Howard P Milstein and members of his family.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section A, line 6</FormAndLineReferenceDesc>
        <ExplanationTxt>The initial member of the Foundation is Howard P Milstein. Additional members may be elected by the existing members from time to time at any annual meeting of members or at any special meeting of members called for election of members.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section A, line 7a</FormAndLineReferenceDesc>
        <ExplanationTxt>Additional members may be elected by the existing members from time to time at any annual meeting of members or at any special meeting of members called for election of members.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, line 11b</FormAndLineReferenceDesc>
        <ExplanationTxt>Prior the filing the form 990 with the IRS, the form 990 is provided to the board of directors. The Foundation's Secretary and Treasurer conduct a detailed review of the form 990 with board members. A copy of the 990 is provided to the board members prior to filing.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, line 12c</FormAndLineReferenceDesc>
        <ExplanationTxt>The foundation maintains a written conflict of interest (COI) policy which is reviewed by management and the board of directors at least annually and modified as required. The board of directors, trustees, officers, key employees, and all other employees of the foundation are required to certify annually any known conflict. The responses to the questionaires are reviewed by management. Management also monitors all transactions during the normal course of business to identify potential conflicts. Individuals who believe they are in a potential conflict are required to recuse themselves from the deliberation and decision making process.All board members have to review and sign off on our Policies and Procedures</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, line 15</FormAndLineReferenceDesc>
        <ExplanationTxt>The foundation has adopted a plan to approve compensation arrangements based on information about compensation paid by similarly situated organizations (taxable or tax-exempt) for similar services, current compensation surveys compiled by independent firms and actual written offers from similarly situated organizations.All board members have to review and sign off on our Policies and Procedures</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section C, line 19</FormAndLineReferenceDesc>
        <ExplanationTxt>Governing documents are available upon request.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part XI, line 9:</FormAndLineReferenceDesc>
        <ExplanationTxt>GAAP ADJUSTMENTS IN ACCORDANCE WITH ASC 720-15 8,727.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>OVERSIGHT PROCESS OR SELECTION PROCESS</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION HAS NOT CHANGED IT'S OVERSIGHT PROCESS OR SELECTION PROCESS</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>